Literature DB >> 1431599

beta-Glucocerebrosidase activity in murine epidermis: characterization and localization in relation to differentiation.

W M Holleran1, Y Takagi, G Imokawa, S Jackson, J M Lee, P M Elias.   

Abstract

The intercellular lipids of the stratum corneum, which are highly enriched in ceramides, are critical for the mammalian epidermal permeability barrier. During the terminal stages of epidermal differentiation, the glucosylceramide content is dramatically reduced, while the content of free ceramides increases. To investigate whether beta-glucocerebrosidase (beta-GlcCer'ase) could be responsible for this change in lipid content, we characterized its activity in murine epidermis, compared enzyme activity to other murine tissues, and localized beta-GlcCer'ase activity within the epidermis. Epidermal extracts demonstrated linear 4-methylumbelliferyl-beta-D-glucose hydrolysis (to 3 h) with protein concentrations between 1 and 250 micrograms/ml. Whole epidermis contained comparable beta-glucosidase activity (9.1 +/- 0.4 nmol/min per mg DNA) to murine brain and liver, and 5-fold higher activity than spleen. Epidermal beta-glucosidase activity was stimulated greater than 15-fold by sodium taurocholate at pH 5.6, and inhibited at acidic pH (3.5-4.0). Bromoconduritol B epoxide (greater than or equal to 1.0 microM), inhibited epidermal enzyme activity by greater than 75%, while activity in brain, liver, and spleen was only inhibited by 6, 17, and 14%, respectively. Moreover, beta-GlcCer'ase mRNA expression in murine epidermis exceeded levels in liver, brain, and spleen. Finally, beta-GlcCer'ase activity was highest in the outer, more differentiated epidermal cell layers including the stratum corneum. In summary, mammalian epidermis contains an usually high percentage (approximately 75%) of beta-glucocerebrosidase activity, and the concentration of activity in the more differentiated cell layers may account for the replacement of glucosylceramide by ceramides in the outer epidermis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1431599

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  15 in total

Review 1.  What is the 'true' function of skin?

Authors:  C M Chuong; B J Nickoloff; P M Elias; L A Goldsmith; E Macher; P A Maderson; J P Sundberg; H Tagami; P M Plonka; K Thestrup-Pederson; B A Bernard; J M Schröder; P Dotto; C M Chang; M L Williams; K R Feingold; L E King; A M Kligman; J L Rees; E Christophers
Journal:  Exp Dermatol       Date:  2002-04       Impact factor: 3.960

2.  Topical hesperidin prevents glucocorticoid-induced abnormalities in epidermal barrier function in murine skin.

Authors:  George Man; Theodora M Mauro; Peggy L Kim; Melanie Hupe; Yongjiao Zhai; Richard Sun; Debbie Crumrine; Carolyn Cheung; Almudena Nuno-Gonzalez; Peter M Elias; Mao-Qiang Man
Journal:  Exp Dermatol       Date:  2014-07-31       Impact factor: 3.960

3.  Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease.

Authors:  W M Holleran; E I Ginns; G K Menon; J U Grundmann; M Fartasch; C E McKinney; P M Elias; E Sidransky
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

4.  Harnessing the glucosyltransferase activities of Clostridium difficile for functional studies of toxins A and B.

Authors:  Charles Darkoh; Heidi B Kaplan; Herbert L Dupont
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

5.  Is the filaggrin-histidine-urocanic acid pathway essential for stratum corneum acidification?

Authors:  Joachim W Fluhr; Peter M Elias; Mao-Qiang Man; Melanie Hupe; Clare Selden; John P Sundberg; Erwin Tschachler; Leopold Eckhart; Theodora M Mauro; Kenneth R Feingold
Journal:  J Invest Dermatol       Date:  2010-04-08       Impact factor: 8.551

6.  Non-pseudogene-derived complex acid beta-glucosidase mutations causing mild type 1 and severe type 2 gaucher disease.

Authors:  M E Grace; P Ashton-Prolla; G M Pastores; A Soni; R J Desnick
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

7.  Effect of formulation pH on transport of naltrexone species and pore closure in microneedle-enhanced transdermal drug delivery.

Authors:  Priyanka Ghosh; Nicole K Brogden; Audra L Stinchcomb
Journal:  Mol Pharm       Date:  2013-05-13       Impact factor: 4.939

8.  Topical peroxisome proliferator activated receptor activators accelerate postnatal stratum corneum acidification.

Authors:  Joachim W Fluhr; Mao-Qiang Man; Jean-Pierre Hachem; Debra Crumrine; Theodora M Mauro; Peter M Elias; Kenneth R Feingold
Journal:  J Invest Dermatol       Date:  2008-08-14       Impact factor: 8.551

9.  Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function.

Authors:  W M Holleran; Y Takagi; G K Menon; G Legler; K R Feingold; P M Elias
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  Glucosylceramides stimulate murine epidermal hyperproliferation.

Authors:  N L Marsh; P M Elias; W M Holleran
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.